Abstract:You have accessJournal of UrologyProstate Cancer: Basic Research I1 Apr 2015MP37-03 INFILTRATING NEUTROPHILS PROMOTE PROSTATE CANCER PROLIFERATION VIA ALTERATION OF IL8-ANDROGEN RECEPTOR SIGNALING Shuai Hu, Yun Cui, Xin Li, Shuyuan Yeh, Jie Jin, Yinglu Guo, and Chawnshang Chang Shuai HuShuai Hu More articles by this author , Yun CuiYun Cui More articles by this author , Xin LiXin Li More articles by this author , Shuyuan YehShuyuan Yeh More articles by this author , Jie JinJie Jin More articles by this author , Yinglu GuoYinglu Guo More articles by this author , and Chawnshang ChangChawnshang Chang More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2015.02.1266AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Early studies found recruited macrophages to prostate cancer (PCa) might enhance PCa cell invasion. However, neutrophils as another major type of myeloid-derived cells impacts on PCa progression remained unclear. Therefore, this study aimed to investigate the possible linkage of neutrophils to the PCa progression. METHODS Human PCa sample survey and in vitro co-culture system were used to detect the neutrophils recruitment by PCa cells (LNCaP, C4-2 and CWR22Rv1). Then the consequences of recruited neutrophils were detected by MTT, Brdu assay and flow cytometry. Q-PCR and cytokine array were used to identify chemokine/cytokine gene expression and cell sources. ShRNA plus cytokine inhibitor were used for interruption assay of signaling. Finally, CWR22Rv1-luc cells were co-injected with neutrophils to nude mice orthotopicly. Tumor growth was detected by IVIS and molecular mechanisms were dissected by IHC staining. RESULTS We found PCa tissues and cells has a better capacity to recruit neutrophils via secreting more chemokine-CXCL1. The consequences of recruitment more neutrophils to PCa cells might then lead to enhanced PCa cells proliferation. Mechanism dissection revealed that co-culture of PCa cells with neutrophils enhanced neutrophils differentiation into the N2 sub-type with increasing cytokine IL8 secretion which might then result in up-regulation of AR signals related to the cell-cycle for the promotion of PCa cell proliferation. Interruption approaches using either neutralization anti-IL8 antibody or AR-siRNA reversed the neutrophils-enhanced PCa cell proliferation. In vivo data also confirmed that infiltrated neutrophils could promote prostate tumor growth with alteration of the expression of related cytokines. CONCLUSIONS We concluded that infiltrating neutrophils could promote PCa growth via modulation of IL8-AR signaling, which may provide a new potential therapeutic approach to better battle PCa via targeting this newly identified signaling from infiltrated neutrophils. © 2015 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 193Issue 4SApril 2015Page: e438 Advertisement Copyright & Permissions© 2015 by American Urological Association Education and Research, Inc.MetricsAuthor Information Shuai Hu More articles by this author Yun Cui More articles by this author Xin Li More articles by this author Shuyuan Yeh More articles by this author Jie Jin More articles by this author Yinglu Guo More articles by this author Chawnshang Chang More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Infiltrating Neutrophils Promote Renal Cell Carcinoma (RCC) Proliferation Via Modulating Androgen Receptor (AR) → C-Myc Signals.

Infiltrating neutrophils promote renal cell carcinoma progression via VEGFa/HIF2 alpha and estrogen receptor beta signals

Androgen Receptor (AR) Signaling Promotes RCC Progression Via Increased Endothelial Cell Proliferation and Recruitment by Modulating AKT → NF-κB → CXCL5 Signaling.

Infiltrating Neutrophils Increase Bladder Cancer Cell Invasion Via Modulation of Androgen Receptor (AR)/MMP13 Signals

Infiltrating mast cells promote renal cell carcinoma angiogenesis by modulating PI3K→︀AKT→︀GSK3β→︀AM signaling

Infiltrating Macrophages Increase RCC Epithelial Mesenchymal Transition (EMT) and Stem Cell-Like Populations Via AKT and Mtor Signaling.

Prognostic model for clear-cell renal cell carcinoma based on natural killer cell-related genes.

Comprehensive analysis of single-cell RNA-seq and bulk RNA-seq revealed the heterogeneity and convergence of the immune microenvironment in renal cell carcinoma

Mp37-03 infiltrating neutrophils promote prostate cancer proliferation via alteration of il8-androgen receptor signaling

Comprehensive investigation of malignant epithelial cell-related genes in clear cell renal cell carcinoma: development of a prognostic signature and exploration of tumor microenvironment interactions

MicroRNA-155-5p Targets NR3C2 to Promote Malignant Progression of Clear Cell Renal Cell Carcinoma

Apolipoprotein C1 stimulates the malignant process of renal cell carcinoma via the Wnt3a signaling

Single-nucleus sequencing unveils heterogeneity in renal cell carcinomas microenvironment: Insights into pathogenic origins and treatment-responsive cellular subgroups

A Positive Feed-Forward Loop Between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 Signaling Promotes Proliferation and Metastasis of Clear Cell Renal Cell Carcinoma

Enhanced IMP3 Expression Activates NF-кB Pathway and Promotes Renal Cell Carcinoma Progression.

Long Noncoding RNA LINC00641 Promotes Renal Cell Carcinoma Progression Via Sponging Microrna-340-5p

Androgen Receptor Decreases Renal Cell Carcinoma Bone Metastases Via Suppressing the Osteolytic Formation Through Altering a Novel Circexoc7 Regulatory Axis.

Epigenetic remodelling shapes inflammatory renal cancer and neutrophil-dependent metastasis

LncRNA-SARCC Suppresses Renal Cell Carcinoma (RCC) Progression Via Altering the Androgen Receptor(ar)/mirna-143-3p Signals

Deciphering the role of miR-187-3p/LRFN1 axis in modulating progression, aerobic glycolysis and immune microenvironment of clear cell renal cell carcinoma

CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition